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Abstract
Neocarzinostatin (NCS), an antibiotic with a high molecular weight, showed an inhibittory
effect on Rauscher mouse leukemia. In normal mice, no significant changes were found in peri·
pheral blood pictures except a tendency of lymphocytopenia, when O. 05mg/kg/day and O.50mg/kg/day
of NCS were injected intraperi. toneally to two groups of mice for three days. On the other hand,
peripheral nucleated cells of Rauscher leukemic mice decreased after intraperitoneal administra-
tion of NCS in a dose over O.25mg/kg/day for three days. The cells affected by NCS were mainly
erythroblasts and smudged cells. Spleens of Rauscher leukemic mice treated with NCS have been
reduced in weight, and histological examinations of livers showed a signicant decrease of infil-
trating cells. In three groups treated with 0.25mg/kg/day of NCS for seven days, O.25mg/kg/day
for three days and O.50mg/kg/day for three days, the.5()% survival time was longer than in the
control group. Particularly, the 50% survival time in Rauscher leukemic mice treated with 0.50
mg/kg/day for three days was over twice that of the control group.
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Abstract: Neocarzinostatin (NCS), an antibiotic with a high
molecular weight, showed an inhibittory effect on Rauscher mouse
leukemia. In normal mice, no significant changes were found in peri·
pheral blood pictures except a tendency of lymphocytopenia, when
O. 05mg/kg/day and O.50mg/kg/day of NCS were injected intraperi.
toneally to two groups of mice for three days. On the other hand,
peripheral nucleated cells of Rauscher leukemic mice decreased after
intraperitoneal administration of NCS in a dose over O.25mg/kg/day
for three days. The cells affected by NCS were mainly erythroblasts
and smudged cells. Spleens of Rauscher leukemic mice treated with
NCS have been reduced in weight, and histological examinations of
livers showed a signicant decrease of infiltrating cells. In three groups
treated with 0.25mg/kg/day of NCS for seven days, O.25mg/kg/day
for three days and O.50mg/kg/day for three days, the.5()% survival
time was longer than in the control group. Particularly, the 50%
survival time in Rauscher leukemic mice treated with 0.50 mg/kg/day
for three days was over twice that of the control group.
Neocarzinostatin (NCS), a new antitumor subutance with a high mole-
cular weight, was first isolated from culture filtrates of Streptomyces carzi-
nostaticus (1). Studies on the effect of NCS in cultures of Sarcina lutea and
HeLa cells revealed specific inhibition of the synthesis of DNA followed by
DNA degradation (2). Up to now, the antitumor effect of NCS has been
recognized in various tumors in mice; sarcoma 180, Ehrlich carcinoma,
hepatoma 134 and L-121O (3, 4). However, the effect on virus-induced
leukemic mice has never been reported. The present paper describes a study
on the effect of NCS on Rauscher leukemic mice.
MATERIALS AND METHODS
Mice used were 1. 5-2. O-month old BALB/c male mice weighing 18-20g.
Leukemic changes were confirmed through changes in peripheral blood and
splenomegaly at the fourth week after the inoculation of 0.2 ml spleen homo.
genates which were obtained from maintaining leukemic mice and suspended
in 20% physiological saline solution. NCS (Lot. 730559 for clinical trial) was
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kindly supplied by the Kayaku Antibiotics Research Laboratory (Tokyo).
Fresh solution of NCS was prepared for each experiment and 0.2 ml of the
solution was injected once daily for three or seven days intraperitoneally.
Dosage of injected NCS was as follows; O.05mg/kg/day, O.25mg/kg/day,
O.50mg/kg/day and l.OOmg/kg/day. Hematological examinations included nuc-
leate cell, red blood cell and thrombocyte counts in peripheral blood. Changes
in the differentials of peripheral nucleate cells, spleen weights and histological
findings of livers were examined in Rauscher leukemic mice treated with
O.50mg/kg/day of NCS for three days. The effect of NCS on survival time was
studied in two groups; one group was treated with each dose of NCS for three
days and another group for seven days.
RESULTS AND DISCUSSION
Effects of NCS on normal mice are shown in Fig 1. No significant
nucleated cell red blood cell thrombocyte
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Fig. 1. Effect of Neocarzinostatin on peripheral blood in nor-
mal BALB/c mice
A: 0.05 mg/kg of NCS was injected for 3 days, i. p, B: 0.50 mg/kg
of NCS was injected for 3 days, i. p, Cell Count (C. C) after injec-
tion of NCS/C. C before injection X 100
changes in peripheral nucleated cell, red blood cell and thrombocyte counts
were found in normal mice injected with O.05mg/kg/day and O.50mg/kg/day
of NCS for three days. Neither any significant changes in the differentials
of peripheral nucleated cells were recognized, except for a tendency of
lymphocytopenia in mice injected with O. 50mg/kg/day of NCS. Effects of
NCS on peripheral nucleate cell counts (NCG) in Rauscher leukemic mice are
shown in Fig. 2. In non-treated Rauscher leukemic mice, NCC increased up
to 128. 3±27. 7% for tnree days. On the other hand, they decreased signi-
ficantly after injection of NCS in a dose more than O.25mg/kg/day for three
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Fig. 2. Effect of Neocarzinostatin on peripheral nucleated cell count in
Rauscher leukemic mice
NCS, injected intraperitoneally for 3 days, • NCC after treat-
ment/NCC before treatment X 100%
273
days. In Rauscher leukemic mice treated with O. 05mgjkgjday of NCS for
three days, NCe were increased slightly although the ratio of the increase
tended to be lower than in the non-treated group. Changes in the differen-
tials of peripheral nucleated cells are demonstrated in Figs. 3 and 4. It is
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Fig. 3. Effect of Neocarzinostatin on differentials of peri-
pheral blood in Rauscher leukemic mice NCS, 0.50 mg/kg/day
x3 days, i. p
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Fig. 4. Smudged cell in peripheral blood Fig. 5. Effect of Neocarzinostatin on
spleen weight in Rauscher leuke-
mic mice
postulated that affected cells with NOS are mainly composed of erythroblasts
and smudged cells. We have already reported hematological findings in
Rauscher leukemic mice (5). In BALB/c mice inoculated with Rauscher
leukemic virus (RLV), erythroblasts begin to appear in the peripheral blood
at around the second or third week and erythroblasts and smudged cells are
gradually increased in quantity as spleen becomes larger. Histologically,
there are marked splenomegaly infiltration, and proliferation of erythro-
blasts in hematopoietic organs. In Rauscher leukemic mice treated with
O. 5mg/kg/day of NOS for three days, the significant decrease in the spleen
weight with a decrease in number of peripheral nucleated cells was recog-
nized (Fig. 5). Infiltrating cells were also decreased in the liver of this group
(Figs. 6, 7).
Effects of NOS on survival time are shown in Fig. 8. Each group was
composed of five Rauscher leukemic mice. When O. 25mg/kg/day, 0.50mg/
kg/day and 1. OOmg/kg/day of NOS was given to three groups for seven days,
a slight prolongation of 50% survival time was recognized only in the group
treated with O. 25mg/kg/day of NOS. In the group treated with 1. OOmg/kg/
day of NOS, Rauscher leukemic mice began to die at day 2 after treatment
and all mice have died during treatment. On the other hand, when 0.25
mg/kg/day or 0.50mg/kg/day of NOS was given for three days, the 50%
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Fig. 8. Effect of Neocarzinostatin on survival
time in Rauscher leukemic mice
survival times were longer than in the control. Particularly, the 50%
survival time of Rauscher leukemic mice treated with O. 50mgjkg/day of
NCS was over twice that of the control. From these results, it can be said
that NCS has also an influence on Rauscher leukemic mice. However, the
question whether or not NCS acts on RLV remains to be solved. Further
studies of antitumor effects of NCS on Rauscher leukemic mice are necessary.
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Fig. 6. Liver of Rauscher leukemic mouse
Ffg. 7. Liver of Rauscher leukemic mouse Ireated with O.50mg/kg/day of Neocarzino-
stalin for 3 days Ii. pi
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